- Home
- CTO vs QSI Comparison
CTO vs QSI Comparison
Compare CTO & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTO | QSI |
|---|---|---|
| Founded | 1902 | 2013 |
| Country | United States | United States |
| Employees | 42 | 145 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 599.1M | 194.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CTO | QSI |
|---|---|---|
| Price | $20.05 | $0.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $22.50 | $1.00 |
| AVG Volume (30 Days) | 245.4K | ★ 6.8M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.63 | N/A |
| Revenue Next Year | $2.76 | $618.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.07 | $0.69 |
| 52 Week High | $20.67 | $3.10 |
Technical Indicators
Market Signals| Indicator | CTO | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 49.67 |
| Support Level | $19.22 | $0.89 |
| Resistance Level | $20.08 | $1.08 |
| Average True Range (ATR) | 0.38 | 0.07 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 43.61 | 36.57 |
Price Performance
Historical ComparisonAbout CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties in diversified markets in the United States. The company operates in four primary business segments: Income properties, management services, commercial loans and investments, and real estate operations. It derives maximum revenue from Income Properties.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.